Cargando…
Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics
PURPOSE: Agomelatine is a novel antidepressant drug suffering from an extensive first-pass metabolism leading to a diminished absolute bioavailability. The aim of the study is: first to enhance its absolute bioavailability, and second to increase its brain delivery. METHODS: To achieve these aims, t...
Autores principales: | Fatouh, Ahmed M, Elshafeey, Ahmed H, Abdelbary, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484509/ https://www.ncbi.nlm.nih.gov/pubmed/28684900 http://dx.doi.org/10.2147/DDDT.S102500 |
Ejemplares similares
-
Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation
por: Fatouh, Ahmed M., et al.
Publicado: (2017) -
Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability
por: Said, Mayada, et al.
Publicado: (2017) -
Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies
por: Elsenosy, Fatma Mohamed, et al.
Publicado: (2020) -
Engineering of a novel optimized platform for sublingual delivery with novel characterization tools: in vitro evaluation and in vivo pharmacokinetics study in human
por: Morsi, Nadia M., et al.
Publicado: (2017) -
Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery
por: Nguyen, Thi-Thao-Linh, et al.
Publicado: (2022)